Keywords
Therapeutic Drug Monitoring; Antipsychotics; Personalized Therapy.
Abstract
Mental disorders have emerged as a significant global challenge in the field of public health, necessitating advanced therapeutic strategies. While antipsychotic agents remain the cornerstone of treatment strategy, conventional population-based drug treatment frequently fails to account for substantial inter-individual variability in pharmacokinetic (PK) and pharmacodynamic (PD) parameters. The emergence of precision medicine frameworks has catalyzed the development of therapeutic drug monitoring (TDM)-guided precision pharmacotherapeutic strategies, which are increasingly recognized as essential tools for optimizing treatment effects. This article synthesizes contemporary research advancements, with a focused analysis of the evolving role of TDM in personalizing antipsychotic regimens. Through critical evaluation of drug-effect relationships, this work elucidates evidence-based strategies to address current limitations in antipsychotic medication management, aiming to inform optimized clinical decision-making for heterogeneous patient populations.
Citation
Xi-Yao W, Chun-Yu L, Li Z, Shu-Jun Y, Shu-Juan P et al, (2025). Therapeutic Drug Monitoring to Guide Precision Pharmacotherapy in Antipsychotic Treatment: A Systematic Review. SM J Neurol Neurosci 11: 8.